Table 1.
Participant demographic and clinical information
| Clinical characteristics | ||||||
|---|---|---|---|---|---|---|
| No. | Sex, Male/Female | Age, y | TC | HDL-C | AI | |
| Discovery set | ||||||
| L | 40 | 20/20 | 60.35 ± 4.96 | 5.54 ± 0.98 | 1.40 ± 0.28 | 2.49 ± 0.65 |
| G | 40 | 20/20 | 60.9 ± 9.64 | 5.86 ± 0.94b | 1.04 ± 0.18b | 4.66 ± 0.53b |
| SL | 40 | 20/20 | 61.05 ± 10.84 | 5.43 ± 0.84a | 1.23 ± 0.12a | 3.04 ± 0.94a |
| SG | 40 | 20/20 | 60.02 ± 11.13 | 5.76 ± 1.76a | 0.98 ± 0.05b | 5.62 ± 1.94b |
| Validation set | ||||||
| L | 80 | 50/30 | 60.53 ± 8.96 | 4.65 ± 0.71 | 1.34 ± 0.27 | 2.39 ± 0.76 |
| G | 80 | 50/30 | 60.89 ± 10.64 | 5.64 ± 0.63a | 1.02 ± 0.12b | 4.76 ± 0.62b |
| SG | 80 | 50/30 | 60.71 ± 10.12 | 5.94 ± 1.26a | 0.95 ± 0.14b | 5.72 ± 0.94b |
Data are presented as mean SD.
Abbreviations: AI, atherosclerosis index; G, AI greater than 4; HDL-C, high-density lipoprotein cholesterol; L, AI less than 4; SG, AI of ischemic stroke greater than 4; SL, AI of ischemic stroke less than 4; TC, total blood cholesterol.
a P less than .05.
b P less than .01, disease group compared to healthy control (AI < 4).